BIOTECH-IGG ApS: Financial statements 2014
CVR: 32099807
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
BIOTECH-IGG ApS (CVR 32099807) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 896,963 and a net result of DKK 388,141 compared with DKK -472,561 the year before. That is an increase of 214.8% compared with the year before. Equity in the 2014 report amounted to DKK 1,036,285. The solvency ratio was 59%.
- Gross Profit
- DKK 896,963
- Profit/Loss
- DKK 388,141
- Equity
- DKK 1,036,285
- Total Assets
- DKK 1,756,560
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 897 t. | 388 t. | 1 mio. | - |
| 2013 | - | 285 t. | -473 t. | 221 t. | - |
| 2012 | - | 361 t. | -371 t. | 693 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
BIOTECH-IGG ApS has published its annual report for 2013. Gross profit came to DKK 284,889, and the net result was DKK -472,561.
As of February 5, 2014, Margareta Anna Kriz has left the board of directors of BIOTECH-IGG ApS.
About BIOTECH-IGG ApS
BIOTECH-IGG ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2009. The company has been dissolved on 3 November 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 2 employees (2017). In 2017, the company reported a gross profit of DKK -102,019 and a net result of DKK -556,494 compared with DKK 12,659 the year before. Equity in the 2017 report amounted to DKK 633,705.